Fenofibrate D4

Fenofibrate D4 is a deuterated analog of fenofibrate, a medication that is primarily used to lower cholesterol levels and triglycerides in the blood. It is a synthetic drug and belongs to the class of fibric acid derivatives. Fenofibrate D4 works by activating peroxisome proliferator-activated receptors (PPARs) in the liver, which leads to an increase in the breakdown of fats and a decrease in the production of triglycerides. This process leads to a reduction in the amount of cholesterol and triglycerides in the bloodstream, thus preventing the development of heart disease. Fenofibrate D4 is commonly used in the treatment of hyperlipidemia, a condition characterized by high levels of lipids (fats) in the blood. It is also prescribed to people with type 2 diabetes who have high levels of triglycerides and low levels of high-density lipoprotein (HDL) cholesterol. Fenofibrate D4 helps to improve glucose metabolism and reduce insulin resistance in these individuals. In terms of chemical information, Fenofibrate D4 has a molecular formula of C20H19ClO4S and a molecular weight of 405.94 g/mol. It is a white, crystalline powder that is soluble in ethanol and methanol but insoluble in water. Fenofibrate D4 is available in various dosage forms, including tablets and capsules, and is typically taken once daily with food. Like all medications, Fenofibrate D4 may cause side effects, including stomach upset, headache, muscle pain, and increased risk of gallstones. It is important to discuss any potential risks and benefits of using this medication with a healthcare provider before starting treatment.